Phase II study of DFP-10917, a deoxycytidine analog, given by 14-day continuous intravenous infusion for chemotherapy-refractory advanced colorectal cancer
| Image |  |
|---|---|
| Description | scientific article published on 13 June 2018 |
| Author/s |
author: Scott Kopetz |
| Publication date | June 13, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |